InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of September 22, 2026, INNV trades at $9.53 with a market cap of $1.45B and a P/E ratio of -529.50. INNV moved +0.66% today. Year to date, INNV is +105.30%; over the trailing twelve months it is +115.25%. Its 52-week range spans $2.60 to $12.64. Analyst consensus is neutral with an average price target of $12.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover INNV: 0 strong buy, 1 buy, 1 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $12.00.
| Metric | Value |
|---|---|
| Price | $9.53 |
| Market Cap | $1.45B |
| P/E Ratio | -529.50 |
| EPS | $-0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.64 |
| 52-Week Low | $2.60 |
| Volume | 197.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $989.71M |
| Net Income | $-683.00K |
| Gross Margin | 23.01% |
3 analysts cover INNV: 0 strong buy, 1 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $12.00.